Daewoong Pharmaceutical Unveils Innovative Drug Delivery Tech
09 Oct 2024 //
PR NEWSWIRE
Daewoong Regaining Rights to Fexuprazan in the USA and Canada
05 Jun 2023 //
PR NEWSWIRE
Daewoong applies for approving its GE reflux drug in 4 Latin American countries
23 May 2022 //
KOREABIOMED
Neurogastrx Agreement with Daewoong Pharmaceutical to Develop Fexuprazan
08 Jun 2021 //
PRNEWSWIRE